Bio Techne's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Bio Techne in the first quarter 2026?
Bio techne Corp achieved a return on average equity (ROE) of 8.22 % in its first quarter 2026, which is below Bio Techne's average return on equity, which stands at 12.66%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Biotechnology & Pharmaceuticals industry 12 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 1893, from total ROE ranking in the fourth quarter 2026 at 1896.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2026) I. Quarter	(Jun 30 2026) IV. Quarter	(Mar 31 2026) III. Quarter	(Dec 31 2025) II. Quarter	(Sep 30 2025) I. Quarter
Y / Y Equity Change	10.17 %	9.87 %	3.33 %	-3.25 %	-
Y / Y Net Income Change	-25.91 %	-	125.99 %	8.94 %	13.65 %
Net Income (TTM) in Millions	172	182	110	81	78
Return On Equity (TTM)	8.22 %	8.9 %	5.49 %	4.1 %	3.91 %
TECH's Total Ranking	# 1893	# 1896	# 1522	# 1790	#
Equity (TTM) in Millions	2,166	2,108	2,085	2,011	1,966
Seq. Equity Change	2.73 %	1.1 %	3.7 %	2.3 %	2.45 %
Seq. Net Income Change	-48.2 %	7 %	34.3 %	-0.46 %	-

Back to TECH Management Effectiveness >> TECH's 5 Years Annual ROE >> Compare TECH ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 13
Sector	# 149
Overall	# 1893

Return On Equity Statistics
High	Average	Low
19.98 %	12.66 %	3.6 %
(Dec 31 2011)		(Jun 30 2025)

TECH Annual Return On Equity	(Jun 30 2026) 2026	(Jun 30 2025) 2025	(Jun 30 2024) 2024	(Jun 30 2023) 2023	(Jun 30 2022) 2022
Total Equity in Millions	2,108	1,919	2,069	1,967	1,701
Y / Y Equity Change	9.87 %	-7.25 %	5.2 %	15.61 %	8.26 %
Net Income in Millions	182	73	168	285	263
Y / Y Net Income Change	147.77 %	-56.34 %	-41.11 %	8.49 %	88.49 %
Return On Equity	8.63 %	3.83 %	8.13 %	14.52 %	15.47 %

Back to TECH Management Effectiveness >> TECH's 5 Years Annual ROE >> Compare TECH ROE to its Competitors

Annual Roe Comment

In 2026 ROE improved to 8.63 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
TECH's' Return on Equity at Yahoo Finance
TECH's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for TECH's Competitors
Subscribers only: Roe for Bio Techne's Suppliers
Subscribers only: Return On Equity for TECH's Customers

Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector	ROE
Msa Safety Inc	21.79 %
Lantheus Holdings Inc	21.72 %
Iqvia Holdings Inc	21.40 %
Denali Therapeutics Inc	21.40 %
West Pharmaceutical Services Inc	21.08 %
Brightspring Health Services Inc	20.31 %
Healthcare Services Group Inc	20.22 %
Vertex Pharmaceuticals Inc	20.08 %
Ge Healthcare Technologies Inc	20.04 %
Neurocrine Biosciences Inc	19.74 %
Ani Pharmaceuticals Inc	19.70 %
Johnson and Johnson	19.55 %
Pediatrix Medical Group Inc	17.28 %
Kiniksa Pharmaceuticals International Plc	17.27 %
Krystal Biotech Inc	17.02 %
Intuitive Surgical Inc	16.99 %
Ensign Group Inc	16.62 %
Lemaitre Vascular Inc	15.81 %
Stryker Corp	15.61 %
Quest Diagnostics Inc	15.22 %
Regeneron Pharmaceuticals Inc	15.07 %
Bio rad Laboratories Inc	14.07 %
Boston Scientific Corporation	13.75 %
Inspire Medical Systems inc	12.49 %
Haemonetics Corporation	12.07 %
Labcorp Holdings Inc	11.55 %
Henry Schein Inc	11.29 %
Medinotec Inc	10.97 %
Tactile Systems Technology Inc	10.73 %
Penumbra Inc	10.44 %

Date modified: 2026-11-09T18:44:30+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.